Security key
74587V107
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)
CUSIP: 74587V107
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,633,071
- Total 13F shares
- 30,964,332
- Share change
- +1,196,069
- Total reported value
- $100,942,686
- Put/Call ratio
- 25%
- Price per share
- $3.26
- Number of holders
- 98
- Value change
- -$1,236,662
- Number of buys
- 56
- Number of sells
- 45
Report period
Q2 2024
Institutions
98
Top holders
10
PBYI full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
PUMA BIOTECHNOLOGY, INC. SEC filings
PUMA BIOTECHNOLOGY, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74587V107
Recent filing periods:
Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
7%
|
3,491,249
|
$18,503,620 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
6.4%
|
3,167,463
|
$16,787,554 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
5.7%
|
2,816,294
|
$14,926,358 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
3.9%
|
1,956,513
|
$10,366,000 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.5%
|
1,729,413
|
$9,166,000 | — | 31 Mar 2024 | |
| Camber Capital Management LP |
13F
|
Company |
3.3%
|
1,650,000
|
$8,745,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.3%
|
1,617,558
|
$8,573,058 | — | 31 Mar 2024 | |
| Eversept Partners, LP |
13F
|
Company |
2.9%
|
1,426,497
|
$7,560,434 | — | 31 Mar 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
2.7%
|
1,343,628
|
$7,121,228 | — | 31 Mar 2024 | |
| Athyrium Capital Management, LP |
13F
|
Company |
2.5%
|
1,256,411
|
$6,658,978 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
617,602
|
$3,273,291 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
568,293
|
$3,011,952 | — | 31 Mar 2024 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.99%
|
491,751
|
$2,606,280 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.91%
|
452,971
|
$2,401,296 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.91%
|
450,580
|
$2,388,075 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.86%
|
429,251
|
$2,275,030 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.78%
|
387,178
|
$2,052,043 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.78%
|
385,863
|
$2,045,074 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.77%
|
382,679
|
$2,028,199 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.75%
|
372,249
|
$1,972,920 | — | 31 Mar 2024 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.58%
|
289,677
|
$1,535,283 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.51%
|
255,300
|
$1,353,090 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.48%
|
238,491
|
$1,264,003 | — | 31 Mar 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.46%
|
230,425
|
$1,221,000 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.43%
|
211,682
|
$1,121,915 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.38%
|
188,893
|
$1,001,132 | — | 31 Mar 2024 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.38%
|
188,283
|
$997,900 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.38%
|
187,585
|
$994,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.35%
|
172,482
|
$914,155 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.34%
|
170,765
|
$905,055 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.32%
|
160,924
|
$852,897 | — | 31 Mar 2024 | |
| Prospera Financial Services Inc |
13F
|
Company |
0.3%
|
147,792
|
$783,292 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.28%
|
140,106
|
$742,562 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
139,400
|
$738,820 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.26%
|
131,175
|
$695,228 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.26%
|
130,473
|
$691,507 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.26%
|
127,231
|
$674,000 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.22%
|
107,900
|
$605,319 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.18%
|
91,690
|
$485,957 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.18%
|
88,029
|
$466,554 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
83,537
|
$442,746 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.16%
|
81,694
|
$432,978 | — | 31 Mar 2024 | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
77,081
|
$408,529 | — | 31 Mar 2024 | |
| Marathon Trading Investment Management LLC |
13F
|
Company |
0.14%
|
70,300
|
$372,590 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.14%
|
70,145
|
$371,769 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.13%
|
62,784
|
$325,008 | — | 31 Mar 2024 | |
| EntryPoint Capital, LLC |
13F
|
Company |
0.12%
|
61,991
|
$328,552 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
60,634
|
$321,360 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.11%
|
54,153
|
$287,011 | — | 31 Mar 2024 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.1%
|
49,875
|
$264,338 | — | 31 Mar 2024 |
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2024
As of 30 Jun 2024,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,964,332 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Frazier Life Sciences Management, L.P., ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GREAT POINT PARTNERS LLC, Eversept Partners, LP, Athyrium Capital Management, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
93
Q2 2024 holders
98
Holder diff
5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.